[go: up one dir, main page]

NO20055002L - Benzol[1,2,5]tiadiazolforbindelser - Google Patents

Benzol[1,2,5]tiadiazolforbindelser

Info

Publication number
NO20055002L
NO20055002L NO20055002A NO20055002A NO20055002L NO 20055002 L NO20055002 L NO 20055002L NO 20055002 A NO20055002 A NO 20055002A NO 20055002 A NO20055002 A NO 20055002A NO 20055002 L NO20055002 L NO 20055002L
Authority
NO
Norway
Prior art keywords
benzo
thiadiazole
cck2
amidophenylsulfanylamino
treatment
Prior art date
Application number
NO20055002A
Other languages
English (en)
Other versions
NO20055002D0 (no
Inventor
Nigel P Shankley
Brett Allison
Laura C Mcatee
Victor K Phuong
Michal H Rabinowitz
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20055002D0 publication Critical patent/NO20055002D0/no
Publication of NO20055002L publication Critical patent/NO20055002L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Det beskrives visse amidofenyl-sulfanylamino-benzo[l,2,5]tiadiazolforbindelser som CCK2 modulatorer som kan benyttes ved behandling av CCK2 medierte sykdommer.
NO20055002A 2003-03-28 2005-10-27 Benzol[1,2,5]tiadiazolforbindelser NO20055002L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US45863803P 2003-03-28 2003-03-28
PCT/US2004/009589 WO2005012275A2 (en) 2003-03-28 2004-03-26 Benzo [1, 2, 5] thiadiazole compounds as cck2 modulators

Publications (2)

Publication Number Publication Date
NO20055002D0 NO20055002D0 (no) 2005-10-27
NO20055002L true NO20055002L (no) 2005-12-14

Family

ID=34115280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20055002A NO20055002L (no) 2003-03-28 2005-10-27 Benzol[1,2,5]tiadiazolforbindelser

Country Status (20)

Country Link
US (2) US7241759B2 (no)
EP (1) EP1675837A2 (no)
JP (1) JP2006528241A (no)
KR (1) KR20050119666A (no)
CN (1) CN1829704A (no)
AU (1) AU2004261547A1 (no)
BR (1) BRPI0408899A (no)
CA (1) CA2520546A1 (no)
CO (1) CO5700819A2 (no)
CR (1) CR8009A (no)
EC (1) ECSP056057A (no)
IS (1) IS8042A (no)
MX (1) MXPA05010484A (no)
NO (1) NO20055002L (no)
NZ (1) NZ542491A (no)
RS (1) RS20050733A (no)
RU (1) RU2005133206A (no)
UA (1) UA82872C2 (no)
WO (1) WO2005012275A2 (no)
ZA (1) ZA200508732B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005085188A2 (en) * 2004-03-02 2005-09-15 Compass Pharmaceuticals Llc Compounds and methods for anti-tumor therapy
MX2007003623A (es) * 2004-09-24 2007-09-11 Johnson & Johnson Compuestos sulfonamida.
US7599588B2 (en) * 2005-11-22 2009-10-06 Vascular Imaging Corporation Optical imaging probe connector
EP1795198A1 (en) * 2005-12-09 2007-06-13 Hubrecht Laboratorium Treatment of Barret's esophagus
WO2008124518A1 (en) * 2007-04-03 2008-10-16 Janssen Pharmaceutica N.V. Oxo-dihydroisoindole sulfonamide compounds as modulators of the cck2 receptor
EP2053052A1 (en) * 2007-10-23 2009-04-29 Laboratorios del Dr. Esteve S.A. Process for the preparation of 6-substituted imidazo[2,1-b]thiazole-5-sulfonyl halide
CA2944788C (en) 2009-06-29 2023-08-22 Agios Pharmaceuticals, Inc. Compounds, and compositions thereof, which modulate pyruvate kinase m2, and methods of making same
RU2532492C1 (ru) * 2013-01-28 2014-11-10 Государственное бюджетное образовательное учреждение высшего профессионального образования "Воронежская государственная медицинская академия им. Н.Н. Бурденко" Министерства здравоохранения Российской Федерации Способ эндоскопического лечения гастродуоденальных язв
MX2016006657A (es) 2013-11-22 2016-10-12 CL BioSciences LLC Antagonistas de gastrina (por ejemplo, yf476, netazepido) para el tratamiento y prevencion de osteoporosis.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2703995B1 (fr) * 1993-04-16 1995-07-21 Sanofi Elf 5-acylamino 1,2,4-thiadiazoles, leur preparation et compositions pharmaceutiques en contenant.
US6239131B1 (en) * 1996-12-10 2001-05-29 Zeria Pharmaceutical Co., Ltd. 1,5 Benzodiazepine derivatives
US6458845B1 (en) * 1999-06-24 2002-10-01 Smithkline Beecham Corporation Macrophage scavenger receptor antagonists
GB0028702D0 (en) 2000-11-24 2001-01-10 Novartis Ag Organic compounds
JP2004529170A (ja) 2001-05-07 2004-09-24 スミスクライン・ビーチャム・コーポレイション スルホンアミド
ITTO20020674A1 (it) 2002-07-26 2004-01-26 Rotta Research Lab Derivati antranilici ad attivita' anticolecistochininica (anti-cck-1), procedimento per la loro preparazione e loro uso farmaceutico

Also Published As

Publication number Publication date
CA2520546A1 (en) 2005-02-10
RS20050733A (sr) 2007-06-04
NO20055002D0 (no) 2005-10-27
BRPI0408899A (pt) 2006-04-18
CO5700819A2 (es) 2006-11-30
NZ542491A (en) 2009-04-30
WO2005012275A2 (en) 2005-02-10
RU2005133206A (ru) 2006-05-10
US7241759B2 (en) 2007-07-10
ECSP056057A (es) 2006-01-27
CR8009A (es) 2008-09-10
US7550492B2 (en) 2009-06-23
UA82872C2 (en) 2008-05-26
JP2006528241A (ja) 2006-12-14
EP1675837A2 (en) 2006-07-05
US20070276016A1 (en) 2007-11-29
IS8042A (is) 2005-09-23
WO2005012275A3 (en) 2006-05-11
ZA200508732B (en) 2007-04-25
KR20050119666A (ko) 2005-12-21
AU2004261547A1 (en) 2005-02-10
CN1829704A (zh) 2006-09-06
US20040224983A1 (en) 2004-11-11
MXPA05010484A (es) 2006-03-10

Similar Documents

Publication Publication Date Title
NO20061122L (no) 2-(Quinoksalin-5-ylsuflonylamino)-benzamid forbindelser som CCK2 modulatorer
WO2004098494A3 (en) Compounds, compositions, and methods
NO20072092L (no) Sulfonamidforbindelser
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
ATE381539T1 (de) Dipeptidylpeptidase-hemmer zur behandlung von diabetes
SG10201809390QA (en) Modulators of indoleamine 2,3-dioxygenase and methods of using the same
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
ATE417051T1 (de) Polymorphe von clopidogrel-hydrogensulfat
WO2005021497A3 (en) Tethered dimers and trimers of 1,4-diphenylazetidn-2-ones
CA2474510A1 (en) Fused tricyclic heterocycles useful for treating hyper-proliferative disorders
NO20031648D0 (no) Farmasöytiske lösninger av modafinilforbindelser
AU2003258145A1 (en) Substituted phenylindoles for the treatment of hiv
WO2005035537A3 (en) Substituted tricyclic heterocycles and their uses
NO20055002L (no) Benzol[1,2,5]tiadiazolforbindelser
ATE419242T1 (de) Pyrrolidinylharnstoffderivate als angiogeneseinhibitoren
IL169646A0 (en) Polyethylene composition for the production of peroxide crosslinked polyethylene
DE60316128D1 (de) N-sulfonylurea-apoptosis-förderer
NO20032406L (no) Anvendelse av 1-fenyl-3-dimetylaminopropanforbindelser for behandling av urininkontinens
MXPA06003345A (es) Derivados de aminopiridina como inhibidores de la no-sintasa inducible.
WO2005117543A3 (en) N-sulfonylcarboximidamide apoptosis promoters
TW200510323A (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
DK1368023T3 (da) Anvendelse af buprenoprphin til behandling af urininkontinens
EP1436279B8 (en) Chemical compounds
AU2003295163A1 (en) Composition for the treatment of hiv or aids
AU2003266093A1 (en) Cyclooct-(en-)yl derivatives for use as fragrances

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application